ArticleDermatology and therapy2026

Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial.

Amy S Paller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.